- Home
- FUN vs KRYS Comparison
FUN vs KRYS Comparison
Compare FUN & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUN
- KRYS
- Stock Information
- Founded
- FUN 1983
- KRYS 2015
- Country
- FUN United States
- KRYS United States
- Employees
- FUN N/A
- KRYS N/A
- Industry
- FUN Services-Misc. Amusement & Recreation
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FUN Consumer Discretionary
- KRYS Health Care
- Exchange
- FUN Nasdaq
- KRYS Nasdaq
- Market Cap
- FUN 4.6B
- KRYS 4.9B
- IPO Year
- FUN 1987
- KRYS 2017
- Fundamental
- Price
- FUN $45.77
- KRYS $182.29
- Analyst Decision
- FUN Strong Buy
- KRYS Strong Buy
- Analyst Count
- FUN 13
- KRYS 7
- Target Price
- FUN $55.92
- KRYS $206.00
- AVG Volume (30 Days)
- FUN 1.4M
- KRYS 266.2K
- Earning Date
- FUN 11-06-2024
- KRYS 11-04-2024
- Dividend Yield
- FUN 2.63%
- KRYS N/A
- EPS Growth
- FUN N/A
- KRYS N/A
- EPS
- FUN 0.37
- KRYS 1.77
- Revenue
- FUN $2,392,739,000.00
- KRYS $241,519,000.00
- Revenue This Year
- FUN $84.47
- KRYS $485.65
- Revenue Next Year
- FUN $4.04
- KRYS $58.64
- P/E Ratio
- FUN $125.05
- KRYS $102.59
- Revenue Growth
- FUN 33.41
- KRYS 2722.80
- 52 Week Low
- FUN $35.93
- KRYS $99.00
- 52 Week High
- FUN $58.70
- KRYS $219.34
- Technical
- Relative Strength Index (RSI)
- FUN 66.84
- KRYS 52.22
- Support Level
- FUN $44.90
- KRYS $168.88
- Resistance Level
- FUN $47.52
- KRYS $207.84
- Average True Range (ATR)
- FUN 1.53
- KRYS 9.66
- MACD
- FUN 0.11
- KRYS -0.29
- Stochastic Oscillator
- FUN 72.65
- KRYS 42.16
About FUN Cedar Fair L.P.
Six Flags Entertainment Corp is North America's regional amusement-resort operator with 27 amusement parks, 15 water parks and nine resort properties across 17 states in the U.S., Canada and Mexico. Six Flags provides coasters, themed rides, thrilling water parks, resorts and a portfolio of beloved intellectual property such as Looney Tunes, DC Comics and PEANUTS.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.